Implementation Strategies and Challenges for Single-Use Technologies at Commercial Scale
Posted on June 22, 2017
Michelle Wong, Engineer
Genentech
Adam Goldstein, Principal Scientist
Genentech/Roche
Background For over 10 years, single-use technology (SUT) has been a growing buzzword in the biomanufacturing industry for its advantages in speed, flexibility, and cost. A recent 2015 BioPlan Associates, Inc. industry survey of biopharmaceutical manufacturers, contract manufacturing organizations, ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
2015 BioPlan Associates, Adam Goldstein, capital investment, CIP, clean-in-place, Eliminates cleaning requirements, Genentech, Genentech/Roche, Implementation strategies, Inc. industry survey, lean manufacturing, Michelle Wong, modular flexible facilities, Network Standardization, Reduces time, Roche, single-use technology, SIP, SKUs, steam in place, stock keeping units, SUT, SUT Materials, vendor initiated changes, VICs
Related Products
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
